How does 3D printing of drugs work?
- At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
- Type: Presentation
- By: KYOBULA, Mary (AstraZeneca, UK)
In 1999, MIT demonstrated the possible application of 3DP to the Pharmaceutical industry 1. Since this time, there has been growing evidence showing the capabilities of 3DP and how it could potentially revolutionise the way medicines are developed, manufactured and delivered to patients. Ultimately it will enable fundamental changes in the health.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.